🔎 Trials Near Me

Home › Graves Ophthalmopathy

Graves Ophthalmopathy clinical trials recruiting in the U.S.

9 studies for Graves Ophthalmopathy are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease

RecruitingPhase 1Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07885605

Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT07753603

Treatment of Chronic Thyroid Eye Disease With MHB018A

RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 14, 2026 · NCT07622121

Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study

RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 14, 2026 · NCT07622108

A Study of VV-14305 for the Treatment of Thyroid Eye Disease

RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Aug 27, 2026 · NCT07404111

An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease

RecruitingPhase 2
Ages 18 to 99 · All sexes · Updated Jul 23, 2026 · NCT07438405

Bimatoprost as a Treatment for Graves' Orbitopathy

RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT03708627

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Feb 25, 2025 · NCT06112340

The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction

RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 23, 2024 · NCT06275373

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.